Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific.

Hamers RL, Oyomopito R, Kityo C, Phanuphak P, Siwale M, Sungkanuparph S, Conradie F, Kumarasamy N, Botes ME, Sirisanthana T, Abdallah S, Li PC, Ngorima N, Kantipong P, Osibogun A, Lee CK, Stevens WS, Kamarulzaman A, Derdelinckx I, Chen YM, Schuurman R, van Vugt M, Rinke de Wit TF; PharmAccess African PASER and TREAT Asia Studies to Evaluate Resistance.

Int J Epidemiol. 2012 Feb;41(1):43-54. doi: 10.1093/ije/dyq192. Epub 2010 Nov 10. No abstract available.

2.

[AIDS treatment in Africa: the risk of antiretroviral resistance].

Hamers RL, Schuurman R, van Vugt M, Derdelinckx I, Rinke de Wit TF.

Ned Tijdschr Geneeskd. 2007 Dec 1;151(48):2666-71. Review. Dutch.

PMID:
18179083
3.

The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa.

Hamers RL, Derdelinckx I, van Vugt M, Stevens W, Rinke de Wit TF, Schuurman R; PharmAccess African Studies to Evaluate Resistance Programme.

Antivir Ther. 2008;13(5):625-39. Review. Erratum in: Antivir Ther. 2008;13(8):1129.

PMID:
18771046
4.

HIV/AIDS care and treatment in sub-Saharan Africa.

Kassaye SG, Katzenstein D.

AIDS Rev. 2003 Oct-Dec;5(4):195-204. Review.

PMID:
15011998
5.

Antiretroviral drug resistance--implications for HIV/AIDS reduction in sub-Saharan Africa and other developing countries.

Obiako OR, Murktar HM, Ogoina D.

Niger J Med. 2010 Oct-Dec;19(4):352-60. Review.

PMID:
21526620
6.

Antiretroviral drug resistance--implications for HIV/AIDS reduction in sub-Saharan Africa and other developing countries.

Obiako OR, Murktar HM, Ogoina D.

Niger J Med. 2010 Jul-Sep;19(3):302-10. Review.

PMID:
20845636
7.

Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review.

Barth RE, van der Loeff MF, Schuurman R, Hoepelman AI, Wensing AM.

Lancet Infect Dis. 2010 Mar;10(3):155-66. doi: 10.1016/S1473-3099(09)70328-7. Review.

PMID:
20185094
8.

Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa.

Sutcliffe CG, van Dijk JH, Bolton C, Persaud D, Moss WJ.

Lancet Infect Dis. 2008 Aug;8(8):477-89. doi: 10.1016/S1473-3099(08)70180-4. Review. Erratum in: Lancet Infect Dis. 2009 Dec;9(12):736.

PMID:
18652994
9.

Non-B HIV-1 subtypes in sub-Saharan Africa: impact of subtype on protease inhibitor efficacy.

Naicker P, Sayed Y.

Biol Chem. 2014 Oct;395(10):1151-61. doi: 10.1515/hsz-2014-0162. Review.

PMID:
25205728
10.

Antiretroviral therapy in sub-Saharan Africa: myth or reality?

Kebba A.

J Antimicrob Chemother. 2003 Nov;52(5):747-9. Epub 2003 Oct 16. Review. No abstract available.

PMID:
14563895
11.

HIV drug resistance assessment in the Western Pacific region. A systematic review.

Yu D, Sutherland D, Ghidinelli M, Jordan M.

AIDS Rev. 2011 Oct-Dec;13(4):214-26. Review.

PMID:
21975357
12.

HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review.

Sigaloff KC, Calis JC, Geelen SP, van Vugt M, de Wit TF.

Lancet Infect Dis. 2011 Oct;11(10):769-79. doi: 10.1016/S1473-3099(11)70141-4. Epub 2011 Aug 25. Review.

PMID:
21872531
13.

Update on HIV-1 acquired and transmitted drug resistance in Africa.

Ssemwanga D, Lihana RW, Ugoji C, Abimiku A, Nkengasong J, Dakum P, Ndembi N.

AIDS Rev. 2015 Jan-Mar;17(1):3-20. Review.

PMID:
25427100
14.

Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world.

Frentz D, Boucher CA, van de Vijver DA.

AIDS Rev. 2012 Jan-Mar;14(1):17-27. Review.

PMID:
22297501
15.

Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis.

Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, Rachlis B, Wu P, Cooper C, Thabane L, Wilson K, Guyatt GH, Bangsberg DR.

JAMA. 2006 Aug 9;296(6):679-90. Review.

PMID:
16896111
16.

Evaluation of drug resistance in HIV infection.

Weissbrich B, Heinkelein M, Jassoy C.

Adv Virus Res. 2002;58:157-202. Review. No abstract available.

PMID:
12205779
17.

Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme.

McGowan CC, Cahn P, Gotuzzo E, Padgett D, Pape JW, Wolff M, Schechter M, Masys DR.

Int J Epidemiol. 2007 Oct;36(5):969-76. Epub 2007 Sep 10. Review. No abstract available.

PMID:
17846055

Supplemental Content

Support Center